Schedule 13G ownership disclosure

MILESTONE PHARMACEUTICALS IN

Security class unavailable · CUSIP: 59935V107

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001319244-24-000053
Form type
SC 13G/A
Filer
INTEGRATED CORE STRATEGIES (US) LLC
CIK
CIK 1319244
Filed
Oct 29, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub